| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 52.11B | 45.48B | 47.07B | 41.63B | 67.13B |
| Gross Profit | 14.61B | 12.81B | 12.92B | 9.09B | 15.85B |
| EBITDA | 8.00B | 6.30B | 6.31B | 4.16B | 8.46B |
| Net Income | 4.86B | 3.52B | 3.51B | 2.31B | 6.27B |
Balance Sheet | |||||
| Total Assets | 133.14B | 123.75B | 130.86B | 123.55B | 122.02B |
| Cash, Cash Equivalents and Short-Term Investments | 15.85B | 15.34B | 17.64B | 19.51B | 21.57B |
| Total Debt | 25.68B | 17.20B | 20.91B | 22.51B | 19.42B |
| Total Liabilities | 73.27B | 63.91B | 71.70B | 66.58B | 63.72B |
| Stockholders Equity | 57.57B | 57.14B | 56.41B | 54.74B | 56.87B |
Cash Flow | |||||
| Free Cash Flow | 219.01M | -1.89B | 812.52M | 894.84M | -288.88M |
| Operating Cash Flow | 4.87B | 2.14B | 2.71B | 2.42B | 2.62B |
| Investing Cash Flow | -5.64B | -2.92B | -278.40M | 567.37M | -1.83B |
| Financing Cash Flow | 465.41M | -679.32M | -2.64B | -2.49B | 2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$144.37B | 11.17 | 14.02% | 3.05% | 12.64% | 2.90% | |
73 Outperform | HK$96.15B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
71 Outperform | HK$14.12B | 8.98 | 11.57% | 4.26% | 2.60% | 49.21% | |
68 Neutral | HK$39.90B | 4.40 | 11.00% | 3.41% | 15.52% | -23.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$14.16B | -11.75 | 10.48% | 4.49% | -9.90% | -20.25% | |
61 Neutral | HK$86.14B | 12.43 | 7.45% | 7.28% | -3.92% | 2.33% |